These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 17488295

  • 1. Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti-coagulant activity.
    Rolla R, Vidali M, Serino R, Pergolini P, Albano E, Bellomo G.
    Clin Exp Immunol; 2007 Jul; 149(1):63-9. PubMed ID: 17488295
    [Abstract] [Full Text] [Related]

  • 2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 3. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M, Dlott J, Norbis F, Ruggeri L, Cler L, Triplett DA, Barbui T.
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [Abstract] [Full Text] [Related]

  • 4. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
    Pengo V, Balestrieri G, Tincani A, Spatola L, Biasiolo A, Brocco T.
    Thromb Haemost; 1997 Jan; 77(1):123-6. PubMed ID: 9031461
    [Abstract] [Full Text] [Related]

  • 5. [Usefulness of silica clotting time for detection of lupus anticoagulants].
    Lee HR, Kim JE, Ha SH, Kim HK, Park S, Cho HI.
    Korean J Lab Med; 2009 Dec; 29(6):497-504. PubMed ID: 20046079
    [Abstract] [Full Text] [Related]

  • 6. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M, Beretta G, Daldossi M, Bevers EM, Barbui T.
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [Abstract] [Full Text] [Related]

  • 7. Antiphospholipid antibodies in pediatric patients with prolonged activated partial thromboplastin time during infection.
    Frauenknecht K, Lackner K, von Landenberg P.
    Immunobiology; 2005 Mar; 210(10):799-805. PubMed ID: 16325500
    [Abstract] [Full Text] [Related]

  • 8. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Mar; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 9. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J, Meijer P, Vermylen J.
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [Abstract] [Full Text] [Related]

  • 10. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M, Finazzi G, Bevers EM, Barbui T.
    Blood; 1995 Jul 15; 86(2):617-23. PubMed ID: 7605991
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
    Kandiah DA, Krilis SA.
    Thromb Haemost; 1998 Aug 15; 80(2):250-7. PubMed ID: 9716148
    [Abstract] [Full Text] [Related]

  • 12. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V, Biasiolo A, Rampazzo P, Brocco T.
    Thromb Haemost; 1999 Feb 15; 81(2):256-8. PubMed ID: 10064002
    [Abstract] [Full Text] [Related]

  • 13. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM, Rodrigues CA, Noguti MA, Matos MF, da Silveira RC, Ribeiro AA, Lourenço DM.
    Blood Coagul Fibrinolysis; 2007 Jul 15; 18(5):401-5. PubMed ID: 17581313
    [Abstract] [Full Text] [Related]

  • 14. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B, Chantarangkul V, Rojnuckarin P, Juntiang J.
    J Med Assoc Thai; 2003 Jun 15; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [Abstract] [Full Text] [Related]

  • 15. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M, Wada H, Watanabe R, Mamamuro M, Okugawa Y, Nakasaki T, Nakase T, Wakita Y, Minamikawa K, Mori Y, Nshikawa M, Shiku H.
    Clin Appl Thromb Hemost; 2000 Jul 15; 6(3):144-50. PubMed ID: 10898274
    [Abstract] [Full Text] [Related]

  • 16. Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper venom time for verification of lupus anticoagulants.
    Alving BM, Barr CF, Johansen LE, Tang DB.
    Thromb Haemost; 1992 Jun 01; 67(6):672-8. PubMed ID: 1509408
    [Abstract] [Full Text] [Related]

  • 17. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T, Julkunen H, Vaarala O, Leirisalo-Repo M, Stephansson E, Vahtera E, Palosuo T, Myllylä G.
    Blood Coagul Fibrinolysis; 1992 Aug 01; 3(4):407-14. PubMed ID: 1420816
    [Abstract] [Full Text] [Related]

  • 18. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
    Kumano O, Amiral J, Dunois C, Peyrafitte M, Moore GW.
    Int J Lab Hematol; 2019 Feb 01; 41(1):60-68. PubMed ID: 30248243
    [Abstract] [Full Text] [Related]

  • 19. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M, Ferrard-Sasson G, Dubucquoi S, Hachulla E, Prin L, Hatron PY, Goudemand J, Boffa MC, Caron C.
    Thromb Haemost; 2009 Mar 01; 101(3):577-81. PubMed ID: 19277423
    [Abstract] [Full Text] [Related]

  • 20. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep 01; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.